GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ENZN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Enzon Pharmaceuticals stock upgraded from Strong Sell Candidate to Hold/Accumulate after Friday trading session.
(Updated on Apr 19, 2024)

Hold candidate since Apr 19, 2024 PDF

No changes to the price of Enzon Pharmaceuticals stock on the last trading day (Friday, 19th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0724 to a day high of $0.0724. The price has risen in 4 of the last 10 days and is up by 3.37% over the past 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.02% during the next 3 months and, with a 90% probability hold a price between $0.0460 and $0.0794 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ENZN Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Enzon Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0780 and $0.0778. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 18, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Friday, April 12, 2024 and based on theory for this formation the price should fall by -5.67% to $0.0683 within 10 trading days since signal was issued (Monday, April 22, 2024).

Support, Risk & Stop-loss for Enzon Pharmaceuticals stock

Enzon Pharmaceuticals finds support from accumulated volume at $0.0700 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 7.19%

Our recommended stop-loss: $0.0694 (-4.06%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ENZN) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Enzon Pharmaceuticals to open at $0.0724, and during the day (based on 14 day Average True Range), to move between $0.0620 and $0.0827, which gives a possible trading interval of +/-$0.0103 (+/-14.26%) up or down from last closing price. If Enzon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 28.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0700 (3.26%) than the resistance at $0.0800 (10.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enzon Pharmaceuticals stock A Buy?

Enzon Pharmaceuticals holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Enzon Pharmaceuticals of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$0.0724 ( 0%) $0.0724

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ENZN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0724 .
R2 0.0724 .
R1 0.0724 .
Current price: 0.0724
Support S1 0.0724 .
S2 0.0724 .
S3 0.0724 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0836 15.46 %
R2 0.0828 14.43 %
R1 0.0800 10.56 %
Current price 0.0724
Support S1 0.0700 -3.26%
S2 0.0620 -14.32%
S3 0.0600 -17.08%

ENZN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 30, 2019 Sep 30, 2019 Oct 15, 2019 $0.120 52.17%
2 Feb 20, 2019 Feb 20, 2019 Feb 20, 2019 $0.0600 26.09%
3 Sep 29, 2017 Sep 29, 2017 Sep 29, 2017 $0.150 62.51%
4 Dec 13, 2016 Dec 13, 2016 Dec 13, 2016 $0.150 44.72%
5 Dec 30, 2015 Dec 30, 2015 Dec 30, 2015 $0.250 36.23%

FAQ

What is the symbol for Enzon Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Enzon Pharmaceuticals is ENZN and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Enzon Pharmaceuticals Stock?
Enzon Pharmaceuticals holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Hold/Accumulate candidate.

How to buy Enzon Pharmaceuticals Stock?
Enzon Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Enzon Pharmaceuticals Stock.

What's the current price of Enzon Pharmaceuticals Stock?
As of the end of day on the 2024-04-19, the price of an Enzon Pharmaceuticals (ENZN) share was $0.0724.

What is the 52-week high and low for Enzon Pharmaceuticals Stock?
The 52-week high for Enzon Pharmaceuticals Stock is $0.230 and the 52-week low is $0.0600.

What is the market capitalization of Enzon Pharmaceuticals Stock?
As of the 2024-04-19, the market capitalization of Enzon Pharmaceuticals is 5.37M.

When is the next earnings date for Enzon Pharmaceuticals?
The upcoming earnings date for Enzon Pharmaceuticals is May 06, 2024.
Click to get the best stock tips daily for free!

About Enzon Pharmaceuticals

Enzon Pharmaceuticals Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.... ENZN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT